行情

AKRXQ

AKRXQ

爱克龙药业
OTCMKTS

实时行情|Nasdaq Last Sale

0.0750
-0.0150
-16.67%
已收盘, 15:59 06/01 EDT
开盘
0.0850
昨收
0.0900
最高
0.0895
最低
0.0600
成交量
2,246.92万
成交额
160.94万
52周最高
5.46
52周最低
0.0600
市值
997.43万
市盈率(TTM)
-0.0237
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AKRXQ价格均价为2.000,最高价位2.000,最低价为2.000。

EPS

AKRXQ 新闻

更多
Penny Stocks to Buy Using Technical Analysis for June 2020
These low-priced stocks may prove exempt from a potential downtrend based on their bullish technical signals.
Investopedia · 3天前
WeWork Board Factions Head for Clash Over New Directors
(Bloomberg) -- WeWork’s board is scheduled to vote on appointing two new directors on Friday, a critical step in a clash between shareholder SoftBank Group Corp. and a rival faction at the troubled co-working startup.A lawyer for WeWork told Delaware Chancery
Bloomberg · 4天前
Akorn Files For Bankruptcy Protection - Existing Equity Holders Will Almost Certainly Be Wiped Out
Seeking Alpha - Article · 5天前
33 Stocks Moving in Wednesday's Pre-Market Session
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares rose 47.8% to $1.22 in pre-market trading after jumping over 33% on Tuesday.
Benzinga · 6天前
96 Biggest Movers From Yesterday
Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019.
Benzinga · 6天前
Akorn, Inc. -- Moody's downgrades Akorn's PDR to D-PD following Chapter 11 filing
Moody's · 6天前
61 Stocks Moving In Tuesday's Mid-Day Session
Gainers Mmtec, Inc. (NASDAQ: MTC) shares jumped 98.2% to $2.18 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019.
Benzinga · 6天前
28 Stocks Moving in Tuesday's Pre-Market Session
Gainers Mmtec, Inc. (NASDAQ: MTC) shares rose 77.2% to $1.95 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797,in 2019.
Benzinga · 05/26 11:18

所属板块

制药
-1.07%
制药与医学研究
-0.77%

热门股票

代码
价格
涨跌幅

AKRXQ 简况

Akorn Inc.是一家专业的制药公司,主要开发、制造及销售通用和品牌处方药品以及自有品牌非处方(OTC)消费者健康产品和动物健康药品。该公司通过两个部门运营:处方药物部和消费者健康部。处方药物部从事制造和销售通用和品牌处方药品业务,包括眼药、注射剂、口服液、耳部、局部吸入剂和鼻喷雾剂。消费者健康部从事制造和营销品牌及自有品牌动物健康和OTC产品业务。该公司的Akorn消费者健康部(ACH)销售一系列OTC品牌和各种自有品牌的OTC药物产品。其OTC品牌为TheraTears Therapy for Your Eyes,是一类治疗眼睛的护理产品。
展开

微牛提供Akorn, Inc.(OTCMKTS-AKRXQ)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AKRXQ股票新闻,以帮助您做出投资决策。